DAVID ALLISON to Glucosides
This is a "connection" page, showing publications DAVID ALLISON has written about Glucosides.
Connection Strength
0.204
-
Unaccounted for regression to the mean renders conclusion of article titled "Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin" unsubstantiated. Diabetes Obes Metab. 2018 08; 20(8):2039-2040.
Score: 0.147
-
A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord. 2004 Nov; 28(11):1411-9.
Score: 0.058